<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.0.38">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">

<meta name="description" content="eBook Companion for Audible Bleeding Podcast Series">

<title>Vascular Surgery Exam Prep - 16&nbsp; CLTI</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<link href="./ali.html" rel="next">
<link href="./claudication.html" rel="prev">
<link href="./images/ab_examprep_icon.png" rel="icon" type="image/png">
<script src="site_libs/cookie-consent/cookie-consent.js"></script>
<link href="site_libs/cookie-consent/cookie-consent.css" rel="stylesheet">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "sidebar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "start",
  "type": "textbox",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-T4DWNE55D1"></script>

<script type="text/plain" cookie-consent="tracking">

window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'G-T4DWNE55D1', { 'anonymize_ip': true});
</script>

<script type="text/javascript" charset="UTF-8">
document.addEventListener('DOMContentLoaded', function () {
cookieconsent.run({
  "notice_banner_type":"simple",
  "consent_type":"implied",
  "palette":"light",
  "language":"en",
  "page_load_consent_levels":["strictly-necessary","functionality","tracking","targeting"],
  "notice_banner_reject_button_hide":false,
  "preferences_center_close_button_hide":false,
  "website_name":""
  });
});
</script> 
  
<script async="" src="https://hypothes.is/embed.js"></script>


<meta property="og:title" content="Vascular Surgery Exam Prep - 16&nbsp; CLTI">
<meta property="og:description" content="eBook Companion for Audible Bleeding Podcast Series">
<meta property="og:site-name" content="Vascular Surgery Exam Prep">
<meta name="twitter:title" content="Vascular Surgery Exam Prep - 16&nbsp; CLTI">
<meta name="twitter:description" content="eBook Companion for Audible Bleeding Podcast Series">
<meta name="twitter:image" content="https://raw.githubusercontent.com/adam-mdmph/vs-examprep/main/images/ab_examprep_cover.png">
<meta name="twitter:card" content="summary_large_image">
</head>

<body class="nav-sidebar floating">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
  <nav class="quarto-secondary-nav" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar" aria-controls="quarto-sidebar" aria-expanded="false" aria-label="Toggle sidebar navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
    <div class="container-fluid d-flex justify-content-between">
      <h1 class="quarto-secondary-nav-title"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">CLTI</span></h1>
      <button type="button" class="quarto-btn-toggle btn" aria-label="Show secondary navigation">
        <i class="bi bi-chevron-right"></i>
      </button>
    </div>
  </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article">
<!-- sidebar -->
  <nav id="quarto-sidebar" class="sidebar collapse sidebar-navigation floating overflow-auto">
    <div class="pt-lg-2 mt-2 text-left sidebar-header">
    <div class="sidebar-title mb-0 py-0">
      <a href="./">Vascular Surgery Exam Prep</a> 
        <div class="sidebar-tools-main">
    <a href="https://github.com/adam-mdmph/vs-examprep.git" title="Source Code" class="sidebar-tool px-1"><i class="bi bi-github"></i></a>
</div>
    </div>
      </div>
      <div class="mt-2 flex-shrink-0 align-items-center">
        <div class="sidebar-search">
        <div id="quarto-search" class="" title="Search"></div>
        </div>
      </div>
    <div class="sidebar-menu-container"> 
    <ul class="list-unstyled mt-1">
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./index.html" class="sidebar-item-text sidebar-link">Preface</a>
  </div>
</li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./authors.html" class="sidebar-item-text sidebar-link">Authors and Contributors</a>
  </div>
</li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">Head and Neck</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-1" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-1" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./cerebrovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">1</span>&nbsp; <span class="chapter-title">Cerebrovascular</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./trauma-cerebrovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">2</span>&nbsp; <span class="chapter-title">Trauma - Cerebrovascular</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true">Upper Extremity</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-2" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-2" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./upper-extremity.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">3</span>&nbsp; <span class="chapter-title">Upper Extremity</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./tos.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">4</span>&nbsp; <span class="chapter-title">Thoracic Outlet</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./hemodialysis.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">5</span>&nbsp; <span class="chapter-title">Hemodialysis</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="true">Thorax</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-3" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-3" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./dissection.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">6</span>&nbsp; <span class="chapter-title">Aortic Dissection</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./taaa.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">7</span>&nbsp; <span class="chapter-title">TAAA</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./aortopathies.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">8</span>&nbsp; <span class="chapter-title">Aortopathies</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./trauma-endovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">9</span>&nbsp; <span class="chapter-title">Trauma - Endo</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true">Abdomen</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-4" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-4" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./abdominal-aneurysms.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">10</span>&nbsp; <span class="chapter-title">AAA</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./mesenteric.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">11</span>&nbsp; <span class="chapter-title">Mesenteric Disease</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./renal.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">12</span>&nbsp; <span class="chapter-title">Renal</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./trauma-arterial.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">13</span>&nbsp; <span class="chapter-title">Trauma - Arterial</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./trauma-venous.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">14</span>&nbsp; <span class="chapter-title">Trauma - Venous</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" aria-expanded="true">Lower Extremity</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-5" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-5" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./claudication.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">PAD Pathogenesis and Claudication</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./clti.html" class="sidebar-item-text sidebar-link active"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">CLTI</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./ali.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">17</span>&nbsp; <span class="chapter-title">Acute Limb Ischemia</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./venous-disease.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">18</span>&nbsp; <span class="chapter-title">Venous Disease</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./trauma-peripheral.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">19</span>&nbsp; <span class="chapter-title">Trauma - Peripheral</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item sidebar-item-section">
      <div class="sidebar-item-container"> 
            <a class="sidebar-item-text sidebar-link text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-6" aria-expanded="true">General</a>
          <a class="sidebar-item-toggle text-start" data-bs-toggle="collapse" data-bs-target="#quarto-sidebar-section-6" aria-expanded="true">
            <i class="bi bi-chevron-right ms-2"></i>
          </a> 
      </div>
      <ul id="quarto-sidebar-section-6" class="collapse list-unstyled sidebar-section depth1 show">  
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./vascular-lab.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">20</span>&nbsp; <span class="chapter-title">Vascular Lab</span></a>
  </div>
</li>
          <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./endovascular.html" class="sidebar-item-text sidebar-link"><span class="chapter-number">21</span>&nbsp; <span class="chapter-title">Endovascular</span></a>
  </div>
</li>
      </ul>
  </li>
        <li class="sidebar-item">
  <div class="sidebar-item-container"> 
  <a href="./references.html" class="sidebar-item-text sidebar-link">References</a>
  </div>
</li>
    </ul>
    </div>
</nav>
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc">
    <h2 id="toc-title">Table of contents</h2>
   
  <ul>
  <li><a href="#etiology-and-presentation" id="toc-etiology-and-presentation" class="nav-link active" data-scroll-target="#etiology-and-presentation"> <span class="header-section-number">16.1</span> Etiology and Presentation</a></li>
  <li><a href="#evaluation" id="toc-evaluation" class="nav-link" data-scroll-target="#evaluation"> <span class="header-section-number">16.2</span> Evaluation</a></li>
  <li><a href="#management" id="toc-management" class="nav-link" data-scroll-target="#management"> <span class="header-section-number">16.3</span> Management</a>
  <ul class="collapse">
  <li><a href="#complications" id="toc-complications" class="nav-link" data-scroll-target="#complications"> <span class="header-section-number">16.3.1</span> Complications</a></li>
  </ul></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title"><span id="sec-clti" class="quarto-section-identifier d-none d-lg-block"><span class="chapter-number">16</span>&nbsp; <span class="chapter-title">CLTI</span></span></h1>
</div>

<div>
  <div class="description">
    eBook Companion for Audible Bleeding Podcast Series
  </div>
</div>


<div class="quarto-title-meta">

    
    
  </div>
  

</header>

<p>Authors: <em>Nedal Katib and Danielle Bajakian</em></p>
<p>Contributor: <em>Eilidh Gunn</em></p>
<div class="cell">
<div class="cell-output-display">
<audio controls=""> <source src="https://traffic.libsyn.com/audiblebleeding/PAOD_part2_postAuphonic.mp3" type="audio/mpeg"> Your browser does not support the audio tag;  for browser support, please see:  https://www.w3schools.com/tags/tag_audio.asp </audio>
</div>
</div>
<section id="etiology-and-presentation" class="level2" data-number="16.1">
<h2 data-number="16.1" class="anchored" data-anchor-id="etiology-and-presentation"><span class="header-section-number">16.1</span> Etiology and Presentation</h2>
<p><strong>How does PAD pathologically progress clinically into Chronic Limb Threatening Ischemia (CLTI)?</strong></p>
<p>The latter stages of both the Rutherford and Fontaine Classification systems highlight this progression, with the Rutherford classification of Stage 5 being specifically minor tissue loss with focal gangrene, and stage 6 as major tissue loss identified by spreading of gangrene beyond the Trans metatarsal level.</p>
<p>Rutherford et al.&nbsp;Ad Hoc Committee on Reporting Standards, SVS/North American Chapter ISCVS:</p>
<table class="table">
<colgroup>
<col style="width: 33%">
<col style="width: 33%">
<col style="width: 33%">
</colgroup>
<thead>
<tr class="header">
<th style="text-align: center;">Grade</th>
<th style="text-align: center;">Category</th>
<th style="text-align: center;">Clinical Description</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td style="text-align: center;">0</td>
<td style="text-align: center;">0</td>
<td style="text-align: center;">Asymptomatic -no hemodynamic significant occlusive disease</td>
</tr>
<tr class="even">
<td style="text-align: center;">I</td>
<td style="text-align: center;">1</td>
<td style="text-align: center;">Mild Claudication</td>
</tr>
<tr class="odd">
<td style="text-align: center;">I</td>
<td style="text-align: center;">2</td>
<td style="text-align: center;">Moderate Claudication</td>
</tr>
<tr class="even">
<td style="text-align: center;">I</td>
<td style="text-align: center;">3</td>
<td style="text-align: center;">Severe Claudication</td>
</tr>
<tr class="odd">
<td style="text-align: center;">II</td>
<td style="text-align: center;">4</td>
<td style="text-align: center;">Ischemic Rest Pain</td>
</tr>
<tr class="even">
<td style="text-align: center;">III</td>
<td style="text-align: center;">5</td>
<td style="text-align: center;">Minor Tissue Loss</td>
</tr>
<tr class="odd">
<td style="text-align: center;">III</td>
<td style="text-align: center;">6</td>
<td style="text-align: center;">Major Tissue Loss</td>
</tr>
</tbody>
</table>
<p><strong>What is Chronic Limb Threatening Ischemia (CLTI), sometimes previously called Critical Limb Ischemia (CLI)?</strong></p>
<p>In the last decade leading up to the 2021 Global Vascular Guidelines (GVG), the term (Chronic Limb threatening Ischemia) CLTI has been gradually replacing CLI. The GVG mentions that their “promotion” of the term CLTI is partly due to terms such as “critical or severe limb ischemia” failing to “recognize the full spectrum and inter-relatedness of components beyond ischemia that contribute to major limb amputation…”</p>
<p><strong>What was the original definition and threshold for CLI, and how can we make sure we elicit the right symptoms from the patient?</strong></p>
<p>John Cranley back in his publication in 1969 defined Ischemic Rest Pain as,</p>
<p>“…pain that occurs in the toes or in the area of the metatarsal heads. Occasionally…in the foot proximal to the metatarsal heads. Elevation of the limb above or at the horizontal position aggravates the pain and pendency…brings relief…” <span class="citation" data-cites="cranleyIschemicRestPain1969">(<a href="references.html#ref-cranleyIschemicRestPain1969" role="doc-biblioref">Cranley 1969</a>)</span></p>
<p><strong><em>Nocturnal Rest Pain:</em></strong> Worse due to horizontal positioning (no gravitational assistance) and systolic BP drop during sleep.</p>
</section>
<section id="evaluation" class="level2" data-number="16.2">
<h2 data-number="16.2" class="anchored" data-anchor-id="evaluation"><span class="header-section-number">16.2</span> Evaluation</h2>
<p><strong>What aspects of the clinical assessment is important?</strong></p>
<p>Clinical Assessment involves a full history (the differential mentioned in Intermittent Claudication) and examination.</p>
<ul>
<li><p><strong>Clinical Examination:</strong></p>
<ul>
<li><p><strong><em>Buergers Test (Beurger 1908) / AKA Ratschows Test</em></strong> (Max-Ratschow-Klinic) identifies when there is critical ischemia without necrosis yet or gangrene, and is characterized by pallor when the leg is elevated above the level of the heart, which then turns red when hanging down over the edge of the bed. This redness is referred to as “Sunset appearance” and its due to abnormal autoregulation. Its been described that normally only a third of the capillary bed is open at any time but in a state of critical ischemia because of the autoregulation being paralyzed a significantly higher portion of the capillaries open up.</p></li>
<li><p><strong><em>The ischemic Angle:</em></strong> A refinement to Berger’s Test: The angle of elevation from the horizontal at which the Doppler Signal of the PT or DP disappears. This is also referred to as the ‘pole test’, whereby the foot is raised alongside a calibrated pole marked in mmHg.</p></li>
</ul></li>
<li><p><strong>Tissue Loss:</strong></p>
<ul>
<li><p>Gangrene Dry or Wet (infection)</p></li>
<li><p>Level of tissue Loss</p></li>
<li><p>Probing To Bone/ Exposed structures: Tendons, Soft Tissue, bone, Joint Capsule.</p></li>
<li><p>Examination of an Ulcer (may have many etiologies) – important not only to identify extent of disease but also to exclude other etiologies:</p>
<ul>
<li>Such as venous, mixed, infective, autoimmune, inflammatory, malignancy or trauma.</li>
</ul></li>
</ul></li>
<li><p><strong>Foot Infection</strong> - Signs of infection, erythema, rubor, cellulitis, tenderness or unexplained hyperglycemia in diabetic patients should prompt urgent referral.<span class="citation" data-cites="kalish2010">(<a href="references.html#ref-kalish2010" role="doc-biblioref">Kalish and Hamdan 2010</a>)</span></p></li>
</ul>
<p><strong>What is the natural history of CLTI and what do we know about its prognosis?</strong></p>
<p>Fortunately, only a small portion of patients with Intermittent Claudication will go on to develop rest pain or tissue loss. Its estimated that anywhere between 5% -29% of patients with PAD or IC go on to develop CLTI over 5 years.</p>
<p>However, those that do develop CLTI, have a high risk of limb loss (greater than 20% annual risk).</p>
<p>CLTI measurements most predictive of non-healing are ankle pressure &lt;50mmHg, ABI &lt;0.4, TcPO2 &lt;20mmHg, and TP &lt;20mmHg.<span class="citation" data-cites="gerhard-herman2017 wickström2017">(<a href="references.html#ref-gerhard-herman2017" role="doc-biblioref">Gerhard-Herman et al. 2017</a>; <a href="references.html#ref-wickström2017" role="doc-biblioref">Wickström et al. 2017</a>)</span></p>
<p>Patients with CLTI have a high mortality risk (10-15% annual risk), the majority of terminal events being related to cardiovascular events. Limb loss or mortality may reach as high as 50% in 1 year. <span class="citation" data-cites="adam2005 norgren2007">(<a href="references.html#ref-adam2005" role="doc-biblioref">Adam et al. 2005</a>; <a href="references.html#ref-norgren2007" role="doc-biblioref">Norgren et al. 2007</a>)</span></p>
<p><strong>What has changed in the last few decades?</strong></p>
<p>Etiologically the prevalence of smokers(Ex and Current) in the population has decreased and the prevalence of diabetes has increased.</p>
<p><strong>What is the WIFI Classification?</strong> <span class="citation" data-cites="millsSocietyVascularSurgery2014a">(<a href="references.html#ref-millsSocietyVascularSurgery2014a" role="doc-biblioref">Mills et al. 2014</a>)</span></p>
<p>Interestingly in the original article by Bob Rutherford regarding Diabetes and PAD:</p>
<p>- “It was generally agreed that diabetic patients who have a varied clinical picture of neuropathy, ischemia and sepsis make the definition even more difficult and it is desirable that these patients be excluded…diabetic patients should be clearly defined as a separate category or should be clearly defined as a separate category.”</p>
<p>Since then, the SVS, while acknowledging that we can no longer exclude these patients and treat them separately given the overlap, have decided that a new classification system is necessary, as one of the key authors (Joseph Mills) states:</p>
<ul>
<li>“We classify things into groups to differentiate, remember and compare, observe and predict their behavior over time.” –Joseph Mills</li>
</ul>
<p><strong><em>WIfI stands for: Wound, Ischemia and foot Infection</em></strong>. Most of the existing Vascular and non-Vascular classification systems don’t include all three components or fail to stratify the degree of ischemia and presence of gangrene.</p>
<p>Principles of WIfI:</p>
<ol type="1">
<li><p><strong><em>Grades, Classes and Stages</em></strong> – Each of the three categories (WIfI) have Grades 0,1,2,3: Resulting in 64 Classes.</p></li>
<li><p><strong><em>Delphi Consensus</em></strong> – Clinical Stages 1 (Very Low),2 (Low), 3 (Moderate), 4 (High Risk/Benefit).</p>
<ol type="1">
<li><p>What is the one-year risk of amputation with medical therapy alone?</p></li>
<li><p>What is the potential benefit from successful revascularization?</p></li>
<li><p>Analogous to TNM Staging</p></li>
</ol></li>
</ol>
<p>“It is intended to be an iterative process with the goal of more precisely stratifying patients according to their initial disease burden, analogous to TNM cancer staging, but not to dictate therapy.”</p>
<p><strong>What about a differential diagnosis or other causes of similar pain as rest pain?</strong></p>
<p>Acute lower limb ischemia has a different clinical presentation, but there may some overlap with Acute on Chronic disease such as in the case of in situ thrombosis in the lower limb arterial system.</p>
<p>Other causes of ischemic pain include:</p>
<ul>
<li><p>Buergers Disease, or Thromboangiitis Obliterans - for more see <a href="upper-extremity.html#sec-buergers-disease"><span>Section&nbsp;3.3.4</span></a></p></li>
<li><p>Scleroderma</p></li>
<li><p>Fibromuscular Dysplasia</p></li>
<li><p>Popliteal Artery Entrapment</p></li>
<li><p>Cystic Adventitial Disease</p></li>
<li><p>Persistent Sciatic Artery Disease</p></li>
</ul>
<p><strong>What is the Rutherford Acute Ischemia Grading System?</strong></p>
<p>Although acute ischemia is very different from chronic ischemia, patients with progressive chronic PAD can develop an acute picture whether from embolism or in-situ thrombosis secondary to plaque rupture. See <a href="ali.html"><span>Chapter&nbsp;17</span></a> for more.</p>
<p><strong>What are the current CLTI Guidelines?</strong></p>
<p>In 2019 the SVS, the ESVS and the World federation of Vascular Societies (WFVS) joined forces to put together the structure and funding of the <strong><em>Global Vascular Guidelines Initiative (GVG)</em></strong>. Importantly all sponsorship was directly from the societies and any direct industry sponsorship or external sources were excluded. They put together a steering committee responsible for recruiting a large and diverse writing group and outlined the scope and developed the section briefs of the guideline.</p>
<p>They determined that:</p>
<ul>
<li><p>“The term”critical limb ischemia” (CLI) is outdated and fails to encompass the full spectrum of patients who are evaluated and treated for limb-threatening ischemia in modern practice.”</p></li>
<li><p>CLTI was promoted as the term of choice and was defined by the target population.</p></li>
<li><p>The target population were:</p>
<ol type="1">
<li><p><strong><em>Ischemic Rest Pain</em></strong> with confirmatory hemodynamic studies.</p></li>
<li><p><strong><em>Diabetic Foot Ulcer</em></strong> or any lower limb ulceration present for at least 2 weeks.</p></li>
<li><p><strong><em>Gangrene</em></strong> involving any portion of the lower limb or foot.</p></li>
</ol></li>
<li><p>Exclusion from the population:</p>
<ol type="1">
<li><p><strong><em>Purely Venous Ulcers</em></strong></p></li>
<li><p><strong><em>Acute Limb Ischemia</em></strong>/acute trash foot/ischemia due to emboli</p></li>
<li><p><strong><em>Acute Trauma</em></strong> or mangled extremity</p></li>
<li><p><strong><em>Wounds secondary to non-atherosclerotic conditions</em></strong></p></li>
</ol></li>
</ul>
<p>Methodology of the guidelines utilized the structure of the <strong><em>GRADE</em></strong> certainty of evidence system.</p>
<p>They highlighted particular important sections in the evaluation and management of patients with CLTI: <strong><em>Patient Risk stratification</em></strong>, <strong><em>Limb Assessment and Severity of Limb Threat</em></strong> and the development of a specific <strong><em>evidence-based revascularisation guideline in CLTI</em></strong>.</p>
<p>It is important to note that compared to most guidelines, unfortunately in the management of CLTI, particularly when it comes to revascularisation, the level of evidence is generally <strong>LOW</strong>. Again, it is important to highlight that the significance of these guidelines in developing a standard approach and appropriately stratifying patients in not only management but ongoing research.</p>
<p><strong>What clinical evaluation is necessary for the patient with CLTI?</strong></p>
<p>In addition to history, examination, and WIfI assessment mentioned above, for patients with diabetes and an ulcer a full assessment of neuropathy and a “probe to bone” test for any open ulcers is recommended as part of good practice.</p>
<p>In the PAD and intermittent claudication sub chapters the non-invasive methods of assessment for these patients have been discussed. In addition it is important to emphasize the role of Toe Pressures (TP) and Toe Pressure Index (TPI) in this cohort of patients.</p>
<p>Healing of an ulcer or tissue loss is unlikely if a patient’s toe pressures are less than 55mmHg. And Toe Pressures have been validated in multiple studies to correlate with Amputation free survival and wound healing: Amputation Free Survival TP &lt;30mmHg 2.13 HR (1.52-2.98). <span class="citation" data-cites="wickström2017 hicks2018">(<a href="references.html#ref-wickström2017" role="doc-biblioref">Wickström et al. 2017</a>; <a href="references.html#ref-hicks2018" role="doc-biblioref">Hicks et al. 2018</a>)</span></p>
<p>Patients with ESRD or DM develop medial calcification and often have elevated ABPI (&gt;1.3) - which is associated with an elevated risk of cardiovascular mortality. Outcomes in patients with ESRD are worse in relation to amputation free survival and amputation rates, regardless of revascularization strategy.<span class="citation" data-cites="meyer2018">(<a href="references.html#ref-meyer2018" role="doc-biblioref">Meyer et al. 2018</a>)</span> Toe pressures are particularly important in this scenario. <span class="citation" data-cites="resnick2004 vitti1994">(<a href="references.html#ref-resnick2004" role="doc-biblioref">Resnick et al. 2004</a>; <a href="references.html#ref-vitti1994" role="doc-biblioref">Vitti et al. 1994</a>)</span></p>
<p>Regarding non-invasive assessment for wound healing, a TcPO2 greater than 40mmHg has the greatest correlation with amputation stump healing.<span class="citation" data-cites="malone1987">(<a href="references.html#ref-malone1987" role="doc-biblioref">Malone et al. 1987</a>)</span></p>
</section>
<section id="management" class="level2" data-number="16.3">
<h2 data-number="16.3" class="anchored" data-anchor-id="management"><span class="header-section-number">16.3</span> Management</h2>
<p><strong>What are the recommendations for patients with CLTI when it comes to Medical Therapy and Risk Factor Modification?</strong></p>
<ul>
<li><p>Treat all patients with CLTI with an <strong>antiplatelet</strong> agent <em>(Grade 1 Level A)</em></p></li>
<li><p>Consider <strong>Clopidogrel</strong> as the single agent (<em>Grade 2 Level B</em>) – CAPRIE<span class="citation" data-cites="capriesteeringcommittee1996">(<a href="references.html#ref-capriesteeringcommittee1996" role="doc-biblioref">Committee 1996</a>)</span></p></li>
<li><p><strong>High-intensity statin therapy</strong> to reduce all-cause and cardiovascular mortality - Atorvastatin 80mg or Rosuvastatin 40mg. These can be titrated down to atorvastatin 40mg or rosuvastatin 20mg if unable to tolerate. (<em>Grade 1 Level A</em>) <span class="citation" data-cites="arya2018 grundy2019">(<a href="references.html#ref-arya2018" role="doc-biblioref">Arya et al. 2018</a>; <a href="references.html#ref-grundy2019" role="doc-biblioref">Grundy et al. 2019</a>)</span></p></li>
<li><p>Control <strong>Hypertension</strong> to BP target &lt;140mm Hg systolic and &lt;90mm Hg diastolic in patients with CLTI (<em>Grade 1 Level B</em>)</p></li>
<li><p>Offer <strong>Smoking Cessation</strong> interventions and ask all smokers or former smokers about status of tobacco use every visit (<em>Grade 1 Level A</em>)</p></li>
<li><p>Diabetic foot wounds with signs of infection, erythema, swelling, pain and foul smelling drainage should be investigated with plain radiography, ESR, CRP, cultures and, managed with iv antibiotics. Signs of systemic sepsis, such as fevers, tachycardia or shock, such as hypotension, should warrant urgent debridement and drainage, regardless of vascular status.</p></li>
</ul>
<p><strong>What imaging assessment is required?</strong></p>
<p>The CLTI Guidelines outline an algorithm of attaining Arterial Anatomical Imaging. Starting with US and then depending on the information required, CTA, MRA, or eventually digital subtraction angiography. They emphasize the importance of obtaining good quality imaging to appropriately stage and be able to compare the level and degree of disease.</p>
<p>For wounds with concern for underlying osteomyelitis - initial workup is with plain radiography, which can identify soft tissue emphysema, evidence of osteomyelitis, or presence of a foreign body. High suspicion of early osteomyelitis with negative x-ray may warrant an MRI.<span class="citation" data-cites="giurato2017">(<a href="references.html#ref-giurato2017" role="doc-biblioref">Giurato et al. 2017</a>)</span></p>
<p><strong>What is the Global Limb Anatomic Staging System (GLASS)?</strong> <span class="citation" data-cites="conteGlobalVascularGuidelines2019a">(<a href="references.html#ref-conteGlobalVascularGuidelines2019a" role="doc-biblioref">Conte et al. 2019</a>)</span></p>
<p>Because the existing arterial anatomical staging of disease is vague, “lesion focused”, and not all encompassing (beyond the concept of ‘in-line pulsatile flow to the foot’), <strong>GLASS</strong> focuses on infrainguinal disease, and attempts to incorporate all aspects in its staging to improve vascular care and evidence-based revascularisation (EBR) outcomes.&nbsp;</p>
<p>GLASS is a grading system based on anatomical and subjective assessment of calcification and incorporates two novel and important concepts:</p>
<ol type="1">
<li><p>The Target Arterial Path (TAP)</p></li>
<li><p>Estimated Limb-Based Patency (LBP)</p></li>
</ol>
<p>As GLASS focuses on Infrainguinal disease, with the aortoiliac (AI) segment considered the inflow disease which includes the Common Femoral Artery and the Profunda Artery. Therefore, the GLASS grades assume the inflow vessels are treated and adequately ‘dealt with’.&nbsp;</p>
<p>Infrainguinal disease assessment for Femoropoliteal (FP) and Infrapopliteal (IP) is based on length of disease and the extent of CTOs. The FP and IP GLASS Grades are then combined into Stages 1-3.&nbsp;</p>
<p>The calcification scale is a dichotomous subjective assessment of the degree of calcification and if there is &gt;50% circumference of calcification, diffuse or bulky calcification or “coral reef” plaques, then there is an increase in the within-segment grade by one numerical value.</p>
<p>There is also mention of the Inframaleolar (IM) degree of disease (PO, P1-absent arch, P2-no target artery crossing into foot) which is not included in the GLASS staging given little evidence on the outcomes this difference makes on overall patency and limb salvage.</p>
<p>Once the GRADES (0-4) of FP and IP disease are determined then staging (1-3) can be performed based on the matrix or grid that is provided. Staging then allows for estimated Peripheral endoVascular Intervention outcomes (PVI) to be predicted, Immediate Technical Failure (ITF - &lt;10% or &lt; 20% or &gt; 20%)) and 1-year Limb Based Patency (LBP - &gt;70%, 50-75% or &lt;50%).&nbsp;</p>
<p><strong>What is the Target Arterial Path (TAP)?</strong></p>
<p>“The selected continuous route of in-line flow from groin to ankle. The TAP typically involves the least diseased IP artery but may be angiosome based.”</p>
<p><strong>Which revascularisation management strategies exist for CLTI?</strong></p>
<p>The mainstay of management for patients with CLTI have always been based on the fundamental principle of limb salvage. Given the high risk of limb loss in these patients there is a low threshold to revascularize these patients if they have occlusive disease that is treatable. But strategy has varied significantly.</p>
<p>The CLTI Guidelines provide an approach to dealing with this complex condition on planning three aspects to each case:</p>
<ol type="1">
<li><p><strong>Patient Risk Estimation</strong></p></li>
<li><p><strong>Limb Staging</strong></p></li>
<li><p><strong>Anatomic Pattern of Disease</strong></p></li>
</ol>
<p><strong>What is involved with the Patient Risk Estimation?</strong></p>
<p><strong><em>Good Practice Statements (Recommendations section 6)</em></strong></p>
<p>“Refer all patients with suspected CLTI to a vascular specialist for consideration of limb salvage, unless major amputation is considered medically urgent.”</p>
<p>“Offer primary amputation or palliation to patients with limited life expectancy, poor functional status (e.g.&nbsp;non ambulatory), or an unsalvageable limb after shared decision-making.”</p>
<p><strong><em>Recommendation 6.3:</em></strong></p>
<ul>
<li><p>Estimate periprocedural risk and life expectancy in patients with CLTI who are candidates for revascularization. <em>Grade 1 (Strong) Level of Evidence C (Low)</em></p></li>
<li><p>Average Surgical Risk: \&lt;5% operative mortality and 2-year survival &gt;50%</p></li>
<li><p>Severe Surgical Risk: \&gt;/= 5% operative mortality and 2-year survival &lt;/=50%</p></li>
</ul>
<p>Understanding disparities is important when interpreting risk for amputation. Observational studies have found certain populations to be at higher risk of amputation regardless of disease severity. These groups include African Americans, lowest median income, medicaid insurance, uninsured, or those from regions with less access to vascular surgeons.<span class="citation" data-cites="hughes2019 ho2005 eslami2007">(<a href="references.html#ref-hughes2019" role="doc-biblioref">Hughes et al. 2019</a>; <a href="references.html#ref-ho2005" role="doc-biblioref">Ho et al. 2005</a>; <a href="references.html#ref-eslami2007" role="doc-biblioref">Eslami, Zayaruzny, and Fitzgerald 2007</a>)</span></p>
<p><strong>What is involved and recommended with the Limb Staging and recommendation for Management?</strong></p>
<ul>
<li><p>Use an integrated threatened limb classification system (such as WIfI) to stage all CLTI patients who are candidates for limb salvage. <em>Grade 1 (Strong) Level of Evidence C (Low)</em></p></li>
<li><p>Perform urgent surgical drainage and debridement (including minor amputation if needed) and commence antibiotic treatment in all patients with suspected CLTI who present with deep space foot infection or wet gangrene. (Good Practice Statement)</p></li>
<li><p>Offer Revascularisation to all “average surgical risk patients” (\&lt;5% operative mortality and 2-year survival &gt;50%) with advanced limb-threatening conditions (e.g.&nbsp;WIfI stage 4) and significant perfusion deficits (e.g.&nbsp;ischemia grades 2 and 3). Particularly if they have good saphenous vein. <em>Grade 1 (Strong) Level of Evidence C (Low)</em> <span class="citation" data-cites="adam2005 norgren2007">(<a href="references.html#ref-adam2005" role="doc-biblioref">Adam et al. 2005</a>; <a href="references.html#ref-norgren2007" role="doc-biblioref">Norgren et al. 2007</a>)</span></p></li>
</ul>
<p><strong>What is involved in the Planning of the Anatomic pattern of disease and its effects of revascularisation strategy?</strong></p>
<p>The overall pattern of arterial occlusive disease is a dominant factor in guiding type of revascularisation and timing of such.</p>
<p><strong>Do all patients require direct in-line flow to the foot as a primary technical outcome with revascularisation?</strong></p>
<p>Patients with rest pain do not necessarily require direct in line flow are those with rest pain “for which correction of inflow disease alone or treatment of FP disease even without continuous tibial runoff to the foot may provide relief of symptoms. This may also be the case in patients presenting with minor degrees of tissue loss.”</p>
<p><strong>What are some essential Key Factors to consider before deciding Open versus Endovascular according to the CLTI guidelines?</strong></p>
<ol type="1">
<li><p><strong>The “availability of and quality of autogenous vein conduit”7</strong></p></li>
<li><p><strong>Patient overall risk (as mentioned above) and Limb Staging</strong></p></li>
<li><p><strong>The Target EndoVascular Intervention (TVI) outcomes</strong></p></li>
</ol>
<p><strong>What evidence do we have for deciding between Endo and Open management? What is the BASIL trial?</strong></p>
<p>The evidence is largely of poor quality, and is largely retrospective or non-controlled, or industry sponsored. <strong>BASIL</strong> (Bypass versus Angioplasty in Severe Ischemia of the Leg) remains the only multicenter RCT (BASIL -2 and 3 underway) directly comparing an endo versus open management strategy for CLTI and Infra-inguinal occlusive disease.&nbsp;</p>
<p>BASIL compared POBA and Bypass across multiple centers (27 centers, n=452, 1999-2004) in the UK. Primary endpoint was Amputation-Free Survival (AFS). <span class="citation" data-cites="bradburyBypassAngioplastySevere2005">(<a href="references.html#ref-bradburyBypassAngioplastySevere2005" role="doc-biblioref">Bradbury et al. 2005</a>)</span></p>
<p>Major Findings:</p>
<ol type="1">
<li><p>At 6-months follow up: no difference in AFS.</p></li>
<li><p>Intention-To-Treat Analysis of overall follow up showed no significant difference in AFS and overall survival.</p></li>
<li><p>Among patients who survived &gt;2 years, overall survival was better for those treated with Bypass as a first approach</p></li>
<li><p>Analysis to treat:</p>
<ul>
<li><p>Prosthetic Bypass Patients did very poorly (even compared to POBA).</p></li>
<li><p>Patients who had bypass after failed POBA had significantly worse AFS compared to those treated with a bypass as initial treatment.</p></li>
</ul></li>
</ol>
<p>Criticism of BASIL:</p>
<ol type="1">
<li><p>Majority had POBA alone (not currently best endovascular option)</p></li>
<li><p>25 % of Open Bypass were Prosthetic</p></li>
<li><p>The technology and technical Skill with growing operator experience in Endovascular has improved.</p></li>
</ol>
<p>For isolated tibial disease, first line endovascular treatment of choice is transluminal, or subintimal angioplasty. Atherectomy, stenting, and drug coated balloons are often used, but should currently not be considered first line, but this data is rapidly evolving. Patency is often poor but limb salvage is reasonable.<span class="citation" data-cites="popplewell2019 kayssi2016 mustapha2016">(<a href="references.html#ref-popplewell2019" role="doc-biblioref">Popplewell and Bradbury 2019</a>; <a href="references.html#ref-kayssi2016" role="doc-biblioref">Kayssi et al. 2016</a>; <a href="references.html#ref-mustapha2016" role="doc-biblioref">Mustapha et al. 2016</a>)</span></p>
<p>Optimal follow up for endovascular interventions of the lower extremity has not yet been established, but should at least include a pulse exam, ABPI and duplex to establish a new baseline after intervention.<span class="citation" data-cites="zierler2018 mohler2012">(<a href="references.html#ref-zierler2018" role="doc-biblioref">Zierler et al. 2018</a>; <a href="references.html#ref-mohler2012" role="doc-biblioref">Mohler et al. 2012</a>)</span></p>
<p><strong>What are the BASIL 2, BASIL 3, and BEST-CLI Trials?</strong></p>
<p><strong>BASIL 2:</strong> Infrapopliteal Disease: Vein Bypass First vs.&nbsp;Best Endovascular Treatment first.</p>
<p><strong>BASIL 3:</strong> PBA +/- BMS vs.&nbsp;DCB +/- BMS vs.&nbsp;DES</p>
<p>(Both Follow up 24-60 months, Primary Endpoint AFS)</p>
<p><strong>BEST-CLI:</strong> Open Bypass versus Endovascular Intervention, Primary Endpoint: MALE-Free Survival. Major Above-the-Ankle Amputation, Major Bypass or Jump/interposition graft revision or the need for thrombectomy or thrombolysis (MALE).</p>
<p><strong>Some important take away lessons for unique scenarios in operative planning for CLTI based on anatomy and conduit.</strong></p>
<ul>
<li><p>Single segment GSV best conduit for infrageniculate bypass. <span class="citation" data-cites="arvela2010 avgerinos2015 moreira2016">(<a href="references.html#ref-arvela2010" role="doc-biblioref">Arvela et al. 2010</a>; <a href="references.html#ref-avgerinos2015" role="doc-biblioref">Avgerinos et al. 2015</a>; <a href="references.html#ref-moreira2016" role="doc-biblioref">Moreira et al. 2016</a>)</span></p></li>
<li><p>Fem-AK pop bypass with prosthetic may be preferred to contralateral GSV. <span class="citation" data-cites="moreira2016">(<a href="references.html#ref-moreira2016" role="doc-biblioref">Moreira et al. 2016</a>)</span> If the target is below the knee, then all autogenous conduits–contralateral GSV, SSV, and spliced arm vein–are preferred over prosthetic grafts.<span class="citation" data-cites="brochadoneto2014 faries2000 taylor1987">(<a href="references.html#ref-brochadoneto2014" role="doc-biblioref">Brochado Neto et al. 2014</a>; <a href="references.html#ref-faries2000" role="doc-biblioref">Faries et al. 2000</a>; <a href="references.html#ref-taylor1987" role="doc-biblioref">Taylor et al. 1987</a>)</span></p></li>
<li><p>Bilateral external iliac occlusion may be best treated with end to side aorto-bifemoral bypass to allow for continued perfusion of the pelvis. <span class="citation" data-cites="jaquinandi2008 vandenakker1992 brewster1978">(<a href="references.html#ref-jaquinandi2008" role="doc-biblioref">Jaquinandi et al. 2008</a>; <a href="references.html#ref-vandenakker1992" role="doc-biblioref">Akker et al. 1992</a>; <a href="references.html#ref-brewster1978" role="doc-biblioref">Brewster and Darling 1978</a>)</span></p></li>
<li><p>Profunda-popliteal collateral index (Segmental pressures AK-BK/AK) of less than 0.25 may suggest that there is sufficient collateral network between profunda and popliteal that SFA treatment may not be necessary. <span class="citation" data-cites="boren1980 mawatari2000">(<a href="references.html#ref-boren1980" role="doc-biblioref">Boren et al. 1980</a>; <a href="references.html#ref-mawatari2000" role="doc-biblioref">Mawatari et al. 2000</a>)</span></p></li>
<li><p>Planning distal bypasses should take into account the angiosome of the wound and the most distal healthy inflow vessel to result in the shortest bypass possible.<span class="citation" data-cites="hingorani2016 jongsma2017">(<a href="references.html#ref-hingorani2016" role="doc-biblioref">Hingorani et al. 2016</a>; <a href="references.html#ref-jongsma2017" role="doc-biblioref">Jongsma et al. 2017</a>)</span></p></li>
<li><p>Intensified anti-thrombotic therapy may be needed in patients with “high risk” infrainguinal bypasses–prosthetic conduit, below the knee target, suboptimal conduit, poor arterial runoff, extensive lesions or tissue loss. Single anti-platelet may not be sufficient, and should be intensified to asa/rivaroxaban, dual antiplatelet, or anticoagulation with Vit K antagonist.<span class="citation" data-cites="conte2015 hussain2018 strobl2013 tepe2012">(<a href="references.html#ref-conte2015" role="doc-biblioref">Conte et al. 2015</a>; <a href="references.html#ref-hussain2018" role="doc-biblioref">Hussain et al. 2018</a>; <a href="references.html#ref-strobl2013" role="doc-biblioref">Strobl et al. 2013</a>; <a href="references.html#ref-tepe2012" role="doc-biblioref">Tepe et al. 2012</a>)</span></p></li>
</ul>
<section id="complications" class="level3" data-number="16.3.1">
<h3 data-number="16.3.1" class="anchored" data-anchor-id="complications"><span class="header-section-number">16.3.1</span> Complications</h3>
<p><strong>What are some complications of lower extremity revascularization procedures?</strong></p>
<p>For a comprehensive list of access complications after endovascular therapy, see <a href="endovascular.html#sec-access-comp"><span>Section&nbsp;21.1.1</span></a></p>
<p>Femoral exploration carries high risk of infection or lymphatic leak. Lymphatic leaks often resolve spontaneously. Infected lymphatic leaks, particularly in the setting of prosthetic bypass require exploration. Should a lymph leak not resolve with conservative management, definitive therapy requires alcohol ablation or muscle flap coverage. The most important aspect of lymph leak is prevention with careful dissection and tissue management during femoral exploration.<span class="citation" data-cites="obara2014 weaver2014">(<a href="references.html#ref-obara2014" role="doc-biblioref">Obara et al. 2014</a>; <a href="references.html#ref-weaver2014" role="doc-biblioref">Weaver et al. 2014</a>)</span></p>


<div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography" style="display: none">
<div id="ref-adam2005" class="csl-entry" role="doc-biblioentry">
Adam, D. J., J. D. Beard, T. Cleveland, J. Bell, A. W. Bradbury, J. F. Forbes, F. G. R. Fowkes, et al. 2005. <span>“Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL): Multicentre, Randomised Controlled Trial.”</span> <em>Lancet (London, England)</em> 366 (9501): 1925–34. <a href="https://doi.org/10.1016/S0140-6736(05)67704-5">https://doi.org/10.1016/S0140-6736(05)67704-5</a>.
</div>
<div id="ref-vandenakker1992" class="csl-entry" role="doc-biblioentry">
Akker, P. J. van den, R. van Schilfgaarde, R. Brand, J. Hajo van Bockel, and J. L. Terpstra. 1992. <span>“Long-Term Results of Prosthetic and Non-Prosthetic Reconstruction for Obstructive Aorto-Iliac Disease.”</span> <em>European Journal of Vascular Surgery</em> 6 (1): 53–61. <a href="https://doi.org/10.1016/s0950-821x(05)80095-7">https://doi.org/10.1016/s0950-821x(05)80095-7</a>.
</div>
<div id="ref-arvela2010" class="csl-entry" role="doc-biblioentry">
Arvela, Eva, Maria Söderström, Anders Albäck, Pekka-Sakari Aho, Maarit Venermo, and Mauri Lepäntalo. 2010. <span>“Arm Vein Conduit Vs Prosthetic Graft in Infrainguinal Revascularization for Critical Leg Ischemia.”</span> <em>Journal of Vascular Surgery</em> 52 (3): 616–23. <a href="https://doi.org/10.1016/j.jvs.2010.04.013">https://doi.org/10.1016/j.jvs.2010.04.013</a>.
</div>
<div id="ref-arya2018" class="csl-entry" role="doc-biblioentry">
Arya, Shipra, Anjali Khakharia, Zachary O. Binney, Randall R. DeMartino, Luke P. Brewster, Philip P. Goodney, and Peter W. F. Wilson. 2018. <span>“Statins Have a Dose-Dependent Effect on Amputation and Survival in Peripheral Artery Disease Patients.”</span> <em>Circulation</em> 137 (14): 1435–46. <a href="https://doi.org/10.1161/CIRCULATIONAHA.117.032361">https://doi.org/10.1161/CIRCULATIONAHA.117.032361</a>.
</div>
<div id="ref-avgerinos2015" class="csl-entry" role="doc-biblioentry">
Avgerinos, Efthymios D., Ulka Sachdev, Abdallah Naddaf, Dannielle R. Doucet, Abhisekh Mohapatra, Steven A. Leers, Rabih A. Chaer, and Michel S. Makaroun. 2015. <span>“Autologous Alternative Veins May Not Provide Better Outcomes Than Prosthetic Conduits for Below-Knee Bypass When Great Saphenous Vein Is Unavailable.”</span> <em>Journal of Vascular Surgery</em> 62 (2): 385–91. <a href="https://doi.org/10.1016/j.jvs.2015.03.025">https://doi.org/10.1016/j.jvs.2015.03.025</a>.
</div>
<div id="ref-boren1980" class="csl-entry" role="doc-biblioentry">
Boren, Clark H, Jonathan B Towne, Victor M Bernhard, and S Salles-Cunha. 1980. <span>“Profundapopliteal Collateral Index. A Guide to Successful Profundaplasty.”</span> <em>Archives of Surgery</em> 115: 1366–72. <a href="https://doi.org/10.1001/archsurg.1980.01380110098015">https://doi.org/10.1001/archsurg.1980.01380110098015</a>.
</div>
<div id="ref-bradburyBypassAngioplastySevere2005" class="csl-entry" role="doc-biblioentry">
Bradbury, Andrew W., D. J. Adam, J. D. Beard, T. Cleveland, J. F. Forbes, F. G. R. Fowkes, I. Gillepsie, C. V. Ruckley, G. Raab, and H. Storkey. 2005. <span>“Bypass Versus Angioplasty in Severe Ischaemia of the Leg (<span>BASIL</span>): <span>Multicentre</span>, Randomised Controlled Trial.”</span> <em>Lancet</em> 366 (9501): 1925–34. <a href="https://doi.org/10.1016/S0140-6736(05)67704-5">https://doi.org/10.1016/S0140-6736(05)67704-5</a>.
</div>
<div id="ref-brewster1978" class="csl-entry" role="doc-biblioentry">
Brewster, D. C., and R. C. Darling. 1978. <span>“Optimal Methods of Aortoiliac Reconstruction.”</span> <em>Surgery</em> 84 (6): 739–48.
</div>
<div id="ref-brochadoneto2014" class="csl-entry" role="doc-biblioentry">
Brochado Neto, F., G. A. Sandri, M. J. Kalaf, M. F. Matielo, I. B. Casella, M. R. Godoy, M. V. Martins Cury, and R. Sacilotto. 2014. <span>“Arm Vein as an Alternative Autogenous Conduit for Infragenicular Bypass in the Treatment of Critical Limb Ischaemia: A 15 Year Experience.”</span> <em>European Journal of Vascular and Endovascular Surgery: The Official Journal of the European Society for Vascular Surgery</em> 47 (6): 609–14. <a href="https://doi.org/10.1016/j.ejvs.2014.01.019">https://doi.org/10.1016/j.ejvs.2014.01.019</a>.
</div>
<div id="ref-capriesteeringcommittee1996" class="csl-entry" role="doc-biblioentry">
Committee, CAPRIE Steering. 1996. <span>“A Randomised, Blinded, Trial of Clopidogrel Versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE).”</span> <em>The Lancet</em> 348 (9038): 1329–39. <a href="https://doi.org/10.1016/S0140-6736(96)09457-3">https://doi.org/10.1016/S0140-6736(96)09457-3</a>.
</div>
<div id="ref-conteGlobalVascularGuidelines2019a" class="csl-entry" role="doc-biblioentry">
Conte, Michael S., Andrew W. Bradbury, Philippe Kolh, John V. White, Florian Dick, Robert Fitridge, Joseph L Mills, Jean-Baptiste Ricco, Kalkunte R. Suresh, and M. Hassan Murad. 2019. <span>“Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.”</span> <em>European Journal of Vascular and Endovascular Surgery : The Official Journal of the European Society for Vascular Surgery</em> 58 (1 Suppl): S1–S109.e33. <a href="https://doi.org/10.1016/j.ejvs.2019.05.006">https://doi.org/10.1016/j.ejvs.2019.05.006</a>.
</div>
<div id="ref-conte2015" class="csl-entry" role="doc-biblioentry">
Conte, Michael S., Frank B. Pomposelli, Daniel G. Clair, Patrick J. Geraghty, James F. McKinsey, Joseph L. Mills, Gregory L. Moneta, et al. 2015. <span>“Society for Vascular Surgery Practice Guidelines for Atherosclerotic Occlusive Disease of the Lower Extremities: Management of Asymptomatic Disease and Claudication.”</span> <em>Journal of Vascular Surgery</em> 61 (3): 2S–41S.e1. <a href="https://doi.org/10.1016/j.jvs.2014.12.009">https://doi.org/10.1016/j.jvs.2014.12.009</a>.
</div>
<div id="ref-cranleyIschemicRestPain1969" class="csl-entry" role="doc-biblioentry">
Cranley, John J. 1969. <span>“Ischemic <span>Rest Pain</span>.”</span> <em>Archives of Surgery</em> 98 (2): 187. <a href="https://doi.org/10.1001/archsurg.1969.01340080079015">https://doi.org/10.1001/archsurg.1969.01340080079015</a>.
</div>
<div id="ref-eslami2007" class="csl-entry" role="doc-biblioentry">
Eslami, Mohammad H., Maksim Zayaruzny, and Gordon A. Fitzgerald. 2007. <span>“The Adverse Effects of Race, Insurance Status, and Low Income on the Rate of Amputation in Patients Presenting with Lower Extremity Ischemia.”</span> <em>Journal of Vascular Surgery</em> 45 (1): 55–59. <a href="https://doi.org/10.1016/j.jvs.2006.09.044">https://doi.org/10.1016/j.jvs.2006.09.044</a>.
</div>
<div id="ref-faries2000" class="csl-entry" role="doc-biblioentry">
Faries, P. L., F. W. Logerfo, S. Arora, M. C. Pulling, D. I. Rohan, C. M. Akbari, D. R. Campbell, G. W. Gibbons, and F. B. Pomposelli. 2000. <span>“Arm Vein Conduit Is Superior to Composite Prosthetic-Autogenous Grafts in Lower Extremity Revascularization.”</span> <em>Journal of Vascular Surgery</em> 31 (6): 1119–27. <a href="https://doi.org/10.1067/mva.2000.106488">https://doi.org/10.1067/mva.2000.106488</a>.
</div>
<div id="ref-gerhard-herman2017" class="csl-entry" role="doc-biblioentry">
Gerhard-Herman, Marie D., Heather L. Gornik, Coletta Barrett, Neal R. Barshes, Matthew A. Corriere, Douglas E. Drachman, Lee A. Fleisher, et al. 2017. <span>“2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.”</span> <em>Circulation</em> 135 (12). <a href="https://doi.org/10.1161/CIR.0000000000000470">https://doi.org/10.1161/CIR.0000000000000470</a>.
</div>
<div id="ref-giurato2017" class="csl-entry" role="doc-biblioentry">
Giurato, Laura, Marco Meloni, Valentina Izzo, and Luigi Uccioli. 2017. <span>“Osteomyelitis in Diabetic Foot: A Comprehensive Overview.”</span> <em>World Journal of Diabetes</em> 8 (4): 135–42. <a href="https://doi.org/10.4239/wjd.v8.i4.135">https://doi.org/10.4239/wjd.v8.i4.135</a>.
</div>
<div id="ref-grundy2019" class="csl-entry" role="doc-biblioentry">
Grundy, Scott M., Neil J. Stone, Alison L. Bailey, Craig Beam, Kim K. Birtcher, Roger S. Blumenthal, Lynne T. Braun, et al. 2019. <span>“2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task&nbsp;Force&nbsp;on&nbsp;Clinical Practice Guidelines.”</span> <em>Journal of the American College of Cardiology</em> 73 (24): e285–350. <a href="https://doi.org/10.1016/j.jacc.2018.11.003">https://doi.org/10.1016/j.jacc.2018.11.003</a>.
</div>
<div id="ref-hicks2018" class="csl-entry" role="doc-biblioentry">
Hicks, Caitlin W., Joseph K. Canner, Nestoras Mathioudakis, Ronald Sherman, Mahmoud B. Malas, James H. Black, and Christopher J. Abularrage. 2018. <span>“The Society for Vascular Surgery Wound, Ischemia, and Foot Infection (WIfI) Classification Independently Predicts Wound Healing in Diabetic Foot Ulcers.”</span> <em>Journal of Vascular Surgery</em> 68 (4): 1096–1103. <a href="https://doi.org/10.1016/j.jvs.2017.12.079">https://doi.org/10.1016/j.jvs.2017.12.079</a>.
</div>
<div id="ref-hingorani2016" class="csl-entry" role="doc-biblioentry">
Hingorani, Anil, Glenn M. LaMuraglia, Peter Henke, Mark H. Meissner, Lorraine Loretz, Kathya M. Zinszer, Vickie R. Driver, et al. 2016. <span>“The Management of Diabetic Foot: A Clinical Practice Guideline by the Society for Vascular Surgery in Collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine.”</span> <em>Journal of Vascular Surgery</em> 63 (2): 3S–21S. <a href="https://doi.org/10.1016/j.jvs.2015.10.003">https://doi.org/10.1016/j.jvs.2015.10.003</a>.
</div>
<div id="ref-ho2005" class="csl-entry" role="doc-biblioentry">
Ho, Vivian, Douglas Wirthlin, Huifeng Yun, and Jeroan Allison. 2005. <span>“Physician Supply, Treatment, and Amputation Rates for Peripheral Arterial Disease.”</span> <em>Journal of Vascular Surgery</em> 42 (1): 81–87. <a href="https://doi.org/10.1016/j.jvs.2005.03.023">https://doi.org/10.1016/j.jvs.2005.03.023</a>.
</div>
<div id="ref-hughes2019" class="csl-entry" role="doc-biblioentry">
Hughes, Kakra, Lucas Mota, Maria Nunez, Neil Sehgal, and Gezzer Ortega. 2019. <span>“The Effect of Income and Insurance on the Likelihood of Major Leg Amputation.”</span> <em>Journal of Vascular Surgery</em> 70 (2): 580–87. <a href="https://doi.org/10.1016/j.jvs.2018.11.028">https://doi.org/10.1016/j.jvs.2018.11.028</a>.
</div>
<div id="ref-hussain2018" class="csl-entry" role="doc-biblioentry">
Hussain, Mohamad A., Mohammed Al-Omran, Mark A. Creager, Sonia S. Anand, Subodh Verma, and Deepak L. Bhatt. 2018. <span>“Antithrombotic Therapy for Peripheral&nbsp;Artery Disease: Recent Advances.”</span> <em>Journal of the American College of Cardiology</em> 71 (21): 2450–67. <a href="https://doi.org/10.1016/j.jacc.2018.03.483">https://doi.org/10.1016/j.jacc.2018.03.483</a>.
</div>
<div id="ref-jaquinandi2008" class="csl-entry" role="doc-biblioentry">
Jaquinandi, Vincent, Jean Picquet, Jean-Louis Saumet, Peyman Benharash, Georges Leftheriotis, and Pierre Abraham. 2008. <span>“Functional Assessment at the Buttock Level of the Effect of Aortobifemoral Bypass Surgery.”</span> <em>Annals of Surgery</em> 247 (5): 869–76. <a href="https://doi.org/10.1097/SLA.0b013e31816bcd75">https://doi.org/10.1097/SLA.0b013e31816bcd75</a>.
</div>
<div id="ref-jongsma2017" class="csl-entry" role="doc-biblioentry">
Jongsma, Hidde, Joost A. Bekken, George P. Akkersdijk, Sanne E. Hoeks, Hence J. Verhagen, and Bram Fioole. 2017. <span>“Angiosome-Directed Revascularization in Patients with Critical Limb Ischemia.”</span> <em>Journal of Vascular Surgery</em> 65 (4): 1208–1219.e1. <a href="https://doi.org/10.1016/j.jvs.2016.10.100">https://doi.org/10.1016/j.jvs.2016.10.100</a>.
</div>
<div id="ref-kalish2010" class="csl-entry" role="doc-biblioentry">
Kalish, Jeffrey, and Allen Hamdan. 2010. <span>“Management of Diabetic Foot Problems.”</span> <em>Journal of Vascular Surgery</em> 51 (2): 476–86. <a href="https://doi.org/10.1016/j.jvs.2009.08.043">https://doi.org/10.1016/j.jvs.2009.08.043</a>.
</div>
<div id="ref-kayssi2016" class="csl-entry" role="doc-biblioentry">
Kayssi, Ahmed, Talal Al‐Atassi, George Oreopoulos, Graham Roche‐Nagle, Kong Teng Tan, and Dheeraj K Rajan. 2016. <span>“Drug‐eluting Balloon Angioplasty Versus Uncoated Balloon Angioplasty for Peripheral Arterial Disease of the Lower Limbs.”</span> <em>The Cochrane Database of Systematic Reviews</em> 2016 (8): CD011319. <a href="https://doi.org/10.1002/14651858.CD011319.pub2">https://doi.org/10.1002/14651858.CD011319.pub2</a>.
</div>
<div id="ref-malone1987" class="csl-entry" role="doc-biblioentry">
Malone, J. M., G. G. Anderson, S. G. Lalka, R. M. Hagaman, R. Henry, K. E. McIntyre, and V. M. Bernhard. 1987. <span>“Prospective Comparison of Noninvasive Techniques for Amputation Level Selection.”</span> <em>American Journal of Surgery</em> 154 (2): 179–84. <a href="https://doi.org/10.1016/0002-9610(87)90174-7">https://doi.org/10.1016/0002-9610(87)90174-7</a>.
</div>
<div id="ref-mawatari2000" class="csl-entry" role="doc-biblioentry">
Mawatari, K., Yoichi Muto, K. Komori, K. Kawasaki, J. Okazaki, D. H. Eguchi, S. Kuma, T. Ikeda, and K. Sugimachi. 2000. <span>“Value of the Profundapopliteal Collateral Index for Selecting Between an in-Flow and Sequential Arterial Reconstruction in Patients with Multisegment Arterial Occlusive Disease.”</span> <em>Journal of Cardiovascular Surgery</em> 41 (January): 79–82.
</div>
<div id="ref-meyer2018" class="csl-entry" role="doc-biblioentry">
Meyer, Alexander, Cornelia Fiessler, Konstantinos Stavroulakis, Giovanni Torsello, Theodosios Bisdas, Werner Lang, and CRITISCH collaborators. 2018. <span>“Outcomes of Dialysis Patients with Critical Limb Ischemia After Revascularization Compared with Patients with Normal Renal Function.”</span> <em>Journal of Vascular Surgery</em> 68 (3): 822–829.e1. <a href="https://doi.org/10.1016/j.jvs.2017.12.048">https://doi.org/10.1016/j.jvs.2017.12.048</a>.
</div>
<div id="ref-millsSocietyVascularSurgery2014a" class="csl-entry" role="doc-biblioentry">
Mills, Joseph L., Michael S. Conte, David G. Armstrong, Frank B. Pomposelli, Andres Schanzer, Anton N. Sidawy, and George Andros. 2014. <span>“The <span>Society</span> for <span>Vascular Surgery Lower Extremity Threatened Limb Classification System</span>: <span>Risk</span> Stratification Based on <span>Wound</span>, <span>Ischemia</span>, and Foot <span>Infection</span> (<span>WIfI</span>).”</span> <em>Journal of Vascular Surgery</em> 59 (1): 220–234.e2. <a href="https://doi.org/10.1016/j.jvs.2013.08.003">https://doi.org/10.1016/j.jvs.2013.08.003</a>.
</div>
<div id="ref-mohler2012" class="csl-entry" role="doc-biblioentry">
Mohler, Emile R., Heather L. Gornik, Marie Gerhard-Herman, Sanjay Misra, Jeffrey W. Olin, R. Eugene Zierler, Michael J. Wolk, et al. 2012. <span>“ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 Appropriate Use Criteria for Peripheral Vascular Ultrasound and Physiological Testing Part i: Arterial Ultrasound and Physiological Testing.”</span> <em>Journal of the American College of Cardiology</em> 60 (3): 242–76. <a href="https://doi.org/10.1016/j.jacc.2012.02.009">https://doi.org/10.1016/j.jacc.2012.02.009</a>.
</div>
<div id="ref-moreira2016" class="csl-entry" role="doc-biblioentry">
Moreira, Carla C., Alexander D. Leung, Alik Farber, Denis Rybin, Gheorghe Doros, Jeffrey J. Siracuse, Jeffrey Kalish, and Mohammad H. Eslami. 2016. <span>“Alternative Conduit for Infrageniculate Bypass in Patients with Critical Limb Ischemia.”</span> <em>Journal of Vascular Surgery</em> 64 (1): 131–139.e1. <a href="https://doi.org/10.1016/j.jvs.2016.01.042">https://doi.org/10.1016/j.jvs.2016.01.042</a>.
</div>
<div id="ref-mustapha2016" class="csl-entry" role="doc-biblioentry">
Mustapha, J. A., Sara M. Finton, Larry J. Diaz-Sandoval, Fadi A. Saab, and Larry E. Miller. 2016. <span>“Percutaneous Transluminal Angioplasty in Patients with Infrapopliteal Arterial Disease: Systematic Review and Meta-Analysis.”</span> <em>Circulation: Cardiovascular Interventions</em> 9 (5): e003468. <a href="https://doi.org/10.1161/CIRCINTERVENTIONS.115.003468">https://doi.org/10.1161/CIRCINTERVENTIONS.115.003468</a>.
</div>
<div id="ref-norgren2007" class="csl-entry" role="doc-biblioentry">
Norgren, L., W. R. Hiatt, J. A. Dormandy, M. R. Nehler, K. A. Harris, and F. G. R. Fowkes. 2007. <span>“Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).”</span> <em>Journal of Vascular Surgery</em> 45 (1): S5–67. <a href="https://doi.org/10.1016/j.jvs.2006.12.037">https://doi.org/10.1016/j.jvs.2006.12.037</a>.
</div>
<div id="ref-obara2014" class="csl-entry" role="doc-biblioentry">
Obara, Andrzej, Miroslaw A. Dziekiewicz, Marek Maruszynski, Adam Witkowski, Maciej Dąbrowski, and Zbigniew Chmielak. 2014. <span>“Lymphatic Complications After Vascular Interventions.”</span> <em>Wideochirurgia I Inne Techniki Maloinwazyjne = Videosurgery and Other Miniinvasive Techniques</em> 9 (3): 420–26. <a href="https://doi.org/10.5114/wiitm.2014.43021">https://doi.org/10.5114/wiitm.2014.43021</a>.
</div>
<div id="ref-popplewell2019" class="csl-entry" role="doc-biblioentry">
Popplewell, Matthew A, and Andrew W Bradbury. 2019. <span>“110. Infrainguinal Disease : Endovascular Therapy.”</span> In <em>Rutherford’s Vascular Surgery and Endovascular Therapy</em>. Elsevier Inc.
</div>
<div id="ref-resnick2004" class="csl-entry" role="doc-biblioentry">
Resnick, Helaine E., Robert S. Lindsay, Mary McGrae McDermott, Richard B. Devereux, Kristina L. Jones, Richard R. Fabsitz, and Barbara V. Howard. 2004. <span>“Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study.”</span> <em>Circulation</em> 109 (6): 733–39. <a href="https://doi.org/10.1161/01.CIR.0000112642.63927.54">https://doi.org/10.1161/01.CIR.0000112642.63927.54</a>.
</div>
<div id="ref-strobl2013" class="csl-entry" role="doc-biblioentry">
Strobl, Frederik F., Klaus Brechtel, Jörg Schmehl, Thomas Zeller, Maximilian F. Reiser, Claus D. Claussen, and Gunnar Tepe. 2013. <span>“Twelve-Month Results of a Randomized Trial Comparing Mono with Dual Antiplatelet Therapy in Endovascularly Treated Patients with Peripheral Artery Disease.”</span> <em>Journal of Endovascular Therapy: An Official Journal of the International Society of Endovascular Specialists</em> 20 (5): 699–706. <a href="https://doi.org/10.1583/13-4275MR.1">https://doi.org/10.1583/13-4275MR.1</a>.
</div>
<div id="ref-taylor1987" class="csl-entry" role="doc-biblioentry">
Taylor, L. M., J. M. Edwards, B. Brant, E. S. Phinney, and J. M. Porter. 1987. <span>“Autogenous Reversed Vein Bypass for Lower Extremity Ischemia in Patients with Absent or Inadequate Greater Saphenous Vein.”</span> <em>American Journal of Surgery</em> 153 (5): 505–10. <a href="https://doi.org/10.1016/0002-9610(87)90803-8">https://doi.org/10.1016/0002-9610(87)90803-8</a>.
</div>
<div id="ref-tepe2012" class="csl-entry" role="doc-biblioentry">
Tepe, Gunnar, Rüdiger Bantleon, Klaus Brechtel, Jörg Schmehl, Thomas Zeller, Claus D. Claussen, and Frederik F. Strobl. 2012. <span>“Management of Peripheral Arterial Interventions with Mono or Dual Antiplatelet Therapy–the MIRROR Study: A Randomised and Double-Blinded Clinical Trial.”</span> <em>European Radiology</em> 22 (9): 1998–2006. <a href="https://doi.org/10.1007/s00330-012-2441-2">https://doi.org/10.1007/s00330-012-2441-2</a>.
</div>
<div id="ref-vitti1994" class="csl-entry" role="doc-biblioentry">
Vitti, M. J., D. V. Robinson, M. Hauer-Jensen, B. W. Thompson, T. J. Ranval, G. Barone, R. W. Barnes, and J. F. Eidt. 1994. <span>“Wound Healing in Forefoot Amputations: The Predictive Value of Toe Pressure.”</span> <em>Annals of Vascular Surgery</em> 8 (1): 99–106. <a href="https://doi.org/10.1007/BF02133411">https://doi.org/10.1007/BF02133411</a>.
</div>
<div id="ref-weaver2014" class="csl-entry" role="doc-biblioentry">
Weaver, Marvin V., Rami O. Tadros, Varinder S. Phangureh, Peter L. Faries, Robert A. Lookstein, and Michael L. Marin. 2014. <span>“A Novel Approach to the Management of a Recurrent Lymphocele Following a Femoral-Femoral Bypass.”</span> <em>Journal of Vascular Surgery</em> 59 (4): 1109–11. <a href="https://doi.org/10.1016/j.jvs.2013.04.049">https://doi.org/10.1016/j.jvs.2013.04.049</a>.
</div>
<div id="ref-wickström2017" class="csl-entry" role="doc-biblioentry">
Wickström, J.-E., M. Laivuori, E. Aro, R. T. Sund, O. Hautero, M. Venermo, J. Jalkanen, and H. Hakovirta. 2017. <span>“Toe Pressure and Toe Brachial Index Are Predictive of Cardiovascular Mortality, Overall Mortality, and Amputation Free Survival in Patients with Peripheral Artery Disease.”</span> <em>European Journal of Vascular and Endovascular Surgery</em> 53 (5): 696–703. <a href="https://doi.org/10.1016/j.ejvs.2017.02.012">https://doi.org/10.1016/j.ejvs.2017.02.012</a>.
</div>
<div id="ref-zierler2018" class="csl-entry" role="doc-biblioentry">
Zierler, R. Eugene, William D. Jordan, Brajesh K. Lal, Firas Mussa, Steven Leers, Joseph Fulton, William Pevec, Andrew Hill, and M. Hassan Murad. 2018. <span>“The Society for Vascular Surgery Practice Guidelines on Follow-up After Vascular Surgery Arterial Procedures.”</span> <em>Journal of Vascular Surgery</em> 68 (1): 256–84. <a href="https://doi.org/10.1016/j.jvs.2018.04.018">https://doi.org/10.1016/j.jvs.2018.04.018</a>.
</div>
</div>
</section>
</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    setTimeout(function() {
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      let href = ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const cites = ref.parentNode.getAttribute('data-cites').split(' ');
    tippyHover(ref, function() {
      var popup = window.document.createElement('div');
      cites.forEach(function(cite) {
        var citeDiv = window.document.createElement('div');
        citeDiv.classList.add('hanging-indent');
        citeDiv.classList.add('csl-entry');
        var biblioDiv = window.document.getElementById('ref-' + cite);
        if (biblioDiv) {
          citeDiv.innerHTML = biblioDiv.innerHTML;
        }
        popup.appendChild(citeDiv);
      });
      return popup.innerHTML;
    });
  }
});
</script>
<nav class="page-navigation">
  <div class="nav-page nav-page-previous">
      <a href="./claudication.html" class="pagination-link">
        <i class="bi bi-arrow-left-short"></i> <span class="nav-page-text"><span class="chapter-number">15</span>&nbsp; <span class="chapter-title">PAD Pathogenesis and Claudication</span></span>
      </a>          
  </div>
  <div class="nav-page nav-page-next">
      <a href="./ali.html" class="pagination-link">
        <span class="nav-page-text"><span class="chapter-number">17</span>&nbsp; <span class="chapter-title">Acute Limb Ischemia</span></span> <i class="bi bi-arrow-right-short"></i>
      </a>
  </div>
</nav>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
      <div class="nav-footer-center"><div class="cookie-consent-footer"><a href="#" id="open_preferences_center">Cookie Preferences</a></div></div>
  </div>
</footer>



</body></html>